Karly A Murphy1, Elizabeth M Stone2, Rachel Presskreischer2, Emma E McGinty2,3, Gail L Daumit1,2,3,4,5,6, Craig E Pollack1,2,5,6. 1. Division of General Internal Medicine, Johns Hopkins School of Medicine. 2. Departments of Health Policy and Management. 3. Mental Health. 4. Psychiatry and Behavioral Sciences. 5. Epidemiology, Johns Hopkins Bloomberg School of Public Health. 6. Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD.
Abstract
BACKGROUND: Persons with serious mental illness (SMI) die 10-20 years earlier than the general population; cancer is the second leading cause of death. Differences in cancer screening between SMI and the general population are not well understood. OBJECTIVES: To describe receipt of cancer screening among individuals with versus without SMI and to explore clinicians' perceptions around cancer screening for people with SMI. METHODS: Mixed-methods study using 2010-2017 MarketScan commercial insurance administrative claims data and semi-structured clinician interviews. In the quantitative analyses, we used multivariate logistic regression analyses to calculate the likelihood of receiving cervical, breast, colorectal, or prostate cancer screening among people with versus without SMI, defined as schizophrenia or bipolar disorder. We conducted semi-structured interviews with 17 primary care physicians and 15 psychiatrists. Interview transcripts were coded using a hybrid deductive/inductive approach. RESULTS: Relative to those without SMI, individuals with SMI were less likely to receive screening for cervical cancer [adjusted odds ratio (aOR): 0.80; 95% confidence interval (CI): 0.80-0.81], breast cancer (aOR: 0.79; 95% CI: 0.78-0.80), colorectal cancer (aOR: 0.90; 95% CI: 0.89-0.91), and prostate cancer (aOR: 0.85; 95% CI: 0.84-0.87). Clinicians identified 5 themes that may help explain the lower rates of cancer screening in persons with SMI: access to care, available support, prioritization of other issues, communication, and patient concerns. CONCLUSIONS: People with SMI were less likely to receive 4 common types of cancer screening. Improving cancer screening rates in the SMI population will likely require a multidisciplinary approach to overcome barriers to screening.
BACKGROUND: Persons with serious mental illness (SMI) die 10-20 years earlier than the general population; cancer is the second leading cause of death. Differences in cancer screening between SMI and the general population are not well understood. OBJECTIVES: To describe receipt of cancer screening among individuals with versus without SMI and to explore clinicians' perceptions around cancer screening for people with SMI. METHODS: Mixed-methods study using 2010-2017 MarketScan commercial insurance administrative claims data and semi-structured clinician interviews. In the quantitative analyses, we used multivariate logistic regression analyses to calculate the likelihood of receiving cervical, breast, colorectal, or prostate cancer screening among people with versus without SMI, defined as schizophrenia or bipolar disorder. We conducted semi-structured interviews with 17 primary care physicians and 15 psychiatrists. Interview transcripts were coded using a hybrid deductive/inductive approach. RESULTS: Relative to those without SMI, individuals with SMI were less likely to receive screening for cervical cancer [adjusted odds ratio (aOR): 0.80; 95% confidence interval (CI): 0.80-0.81], breast cancer (aOR: 0.79; 95% CI: 0.78-0.80), colorectal cancer (aOR: 0.90; 95% CI: 0.89-0.91), and prostate cancer (aOR: 0.85; 95% CI: 0.84-0.87). Clinicians identified 5 themes that may help explain the lower rates of cancer screening in persons with SMI: access to care, available support, prioritization of other issues, communication, and patient concerns. CONCLUSIONS: People with SMI were less likely to receive 4 common types of cancer screening. Improving cancer screening rates in the SMI population will likely require a multidisciplinary approach to overcome barriers to screening.
Authors: Erin Anne Kaufman; Michael G McDonell; Margaret A Cristofalo; Richard K Ries Journal: Issues Ment Health Nurs Date: 2012-03 Impact factor: 1.835
Authors: Faith Dickerson; Jennifer Schroeder; Emily Katsafanas; Sunil Khushalani; Andrea E Origoni; Christina Savage; Lucy Schweinfurth; Catherine R Stallings; Kevin Sweeney; Robert H Yolken Journal: Psychiatr Serv Date: 2017-09-15 Impact factor: 3.084
Authors: D I Velligan; C C Bow-Thomas; C Huntzinger; J Ritch; N Ledbetter; T J Prihoda; A L Miller Journal: Am J Psychiatry Date: 2000-08 Impact factor: 18.112
Authors: Monique James; Melanie Thomas; Latoya Frolov; Nicholas S Riano; Eric Vittinghoff; Dean Schillinger; John W Newcomer; Christina Mangurian Journal: Psychiatr Serv Date: 2017-04-17 Impact factor: 3.084
Authors: Robert T Dess; Holly E Hartman; Brandon A Mahal; Payal D Soni; William C Jackson; Matthew R Cooperberg; Christopher L Amling; William J Aronson; Christopher J Kane; Martha K Terris; Zachary S Zumsteg; Santino Butler; Joseph R Osborne; Todd M Morgan; Rohit Mehra; Simpa S Salami; Amar U Kishan; Chenyang Wang; Edward M Schaeffer; Mack Roach; Thomas M Pisansky; William U Shipley; Stephen J Freedland; Howard M Sandler; Susan Halabi; Felix Y Feng; James J Dignam; Paul L Nguyen; Matthew J Schipper; Daniel E Spratt Journal: JAMA Oncol Date: 2019-07-01 Impact factor: 31.777
Authors: Karly A Murphy; Gail L Daumit; Emma E McGinty; Elizabeth M Stone; Alene Kennedy-Hendricks Journal: Psychooncology Date: 2021-09-19 Impact factor: 3.894
Authors: Karly A Murphy; Arlene Dalcin; Emma E McGinty; Stacy Goldsholl; Ann Heller; Gail L Daumit Journal: Front Psychiatry Date: 2021-12-22 Impact factor: 4.157
Authors: Rahma S Mkuu; Stephanie A Staras; Sarah M Szurek; Dalila D'Ingeo; Mary A Gerend; Dianne L Goede; Elizabeth A Shenkman Journal: BMC Cancer Date: 2022-03-09 Impact factor: 4.430
Authors: Fahrin Ramadan Andiwijaya; Calum Davey; Khaoula Bessame; Abdourahmane Ndong; Hannah Kuper Journal: Int J Environ Res Public Health Date: 2022-08-02 Impact factor: 4.614